Company Valuation: Edwards Lifesciences Corporation

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 80,883 46,128 46,246 43,663 49,471 51,818 - -
Change - -42.97% 0.25% -5.58% 13.3% 4.75% - -
Enterprise Value (EV) 1 80,616 45,956 45,198 40,285 45,843 48,187 46,624 44,808
Change - -42.99% -1.65% -10.87% 13.8% 5.12% -3.25% -3.89%
P/E 54.4x 30.6x 33.2x 10.6x 46.6x 35.5x 27.2x 24.2x
PBR 13.9x 7.82x 6.99x 4.36x 4.79x 4.88x 4.25x 3.94x
PEG - 12.14x -5.79x 0x -0.6x 0.9x 0.9x 1.9x
Capitalization / Revenue 15.5x 8.57x 7.7x 8.03x 8.15x 7.67x 6.98x 6.34x
EV / Revenue 15.4x 8.54x 7.53x 7.41x 7.56x 7.13x 6.28x 5.48x
EV / EBITDA 46.6x 23.7x 24.1x 24.1x 25.5x 22.5x 19.6x 16.7x
EV / EBIT 50.6x 25.6x 26.1x 26.6x 27.9x 24.5x 21.1x 18x
EV / FCF 57.3x 47.2x 47.9x 139x 34.3x 56.8x 29x 24.6x
FCF Yield 1.74% 2.12% 2.09% 0.72% 2.91% 1.76% 3.45% 4.06%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 2.38 2.44 2.3 6.97 1.83 2.531 3.304 3.718
Distribution rate - - - - - - - -
Net sales 1 5,232 5,382 6,005 5,440 6,068 6,759 7,429 8,177
EBITDA 1 1,729 1,936 1,879 1,670 1,800 2,137 2,384 2,687
EBIT 1 1,594 1,796 1,734 1,514 1,644 1,971 2,212 2,484
Net income 1 1,503 1,522 1,402 4,175 1,074 1,435 1,897 2,121
Net Debt 1 -267 -172.7 -1,048 -3,378 -3,628 -3,631 -5,195 -7,011
Reference price 2 129.55 74.61 76.25 74.03 85.25 89.90 89.90 89.90
Nbr of stocks (in thousands) 6,24,334 6,18,260 6,06,500 5,89,800 5,80,300 5,76,400 - -
Announcement Date 26/01/22 31/01/23 06/02/24 11/02/25 10/02/26 - - -
1USD in Million2USD
Estimates

P/E, Detailed evolution



P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
35.52x7.13x22.55x-.--% 5.18TCr
30.5x5.4x20.72x0.3% 23TCr
35.03x6.31x20.02x0.69% 15TCr
40.22x10.44x23.09x-.--% 13TCr
17.84x3.65x11.85x-.--% 6.93TCr
19.37x2.33x11.69x2.63% 5.04TCr
29.39x5.8x19.69x0.68% 4.25TCr
71.67x6.84x20.83x-.--% 4.02TCr
44.12x7.18x25.33x-.--% 3.3TCr
19.57x5.5x14.21x1.16% 3.29TCr
Average 34.32x 6.06x 19.00x 0.55% 8.23TCr
Weighted average by Cap. 33.47x 6.30x 19.66x 0.45%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA



Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. EW Stock
  4. Valuation Edwards Lifesciences Corporation